News | April 2, 2014

Relypsa Names Sylvia R. Wheeler V.P. Investor Relations and Corporate Affairs REDWOOD CITY, Calif., April 2, 2014 (GLOBE NEWSWIRE) — Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced the appointment of Sylvia R. Wheeler to the position of...

News | April 2, 2014

Premier, Inc. Identifies Kit Check as “Technology Breakthrough Product” – awards exclusive agreement for pharmacy kit medication tracking solution Washington, DC – April 2, 2014 – Premier, Inc., a leading healthcare improvement company uniting an...

News | April 2, 2014

Cardinal Health Expands Portfolio of Physician Preference Items Company to Acquire AccessClosure, a Leading U.S. Manufacturer of Extravascular Closure Devices – Expands Cardinal Health portfolio of preferred products that meet increasing demand for high quality,...

News | April 7, 2014

CardioKinetix Releases One-Year Clinical Data Showing Consistent, Compelling Positive Results for Patients Treated with Minimally Invasive Structural Heart Device for Heart Failure Analysis from 111 Consecutive Patients Presented at ACC 2014 Substantiate Potential of...

News | April 9, 2014

Chimerix Announces Appointment of M. Michelle Berrey, M.D., M.P.H. as Chief Executive Officer DURHAM, N.C., April 9, 2014 — Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today...